DOSSIER · 13F Holders · Q3 2026

NEWAMSTERDAM PHARMA COMPANY

12 institutions still hold NEWAMSTERDAM PHARMA COMPANY as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP N62509117·12 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$28M
visible holders
Holders
12
filers reporting
Concentration
38.61%
Frazier Life Sciences Management, L.P. #1
top holder share
AI Holders Summary · Q3 2026

12 institutions reported NEWAMSTERDAM PHARMA COMPANY in Q3 2026. Frazier Life Sciences Management, L.P. leads at 38.6% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Frazier Life Sciences Management, L.P.
CIK 0001892134
$11M500K0.23%Q2 2026
02
RA CAPITAL MANAGEMENT, L.P.
CIK 0001346824
$7M333K0.06%Q2 2026
03
Affinity Asset Advisors, LLC
CIK 0001773195
$3M245K0.13%Q3 2026
04
Bain Capital Life Sciences Investors, LLC
CIK 0001703031
$2M100K0.13%Q2 2026
05
DEERFIELD MANAGEMENT COMPANY, L.P.
CIK 0001009258
$2M93K0.03%Q4 2025
06
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
$2M75K0.00%Q2 2026
07
ARISTEIA CAPITAL, L.L.C.
CIK 0001080171
$343K16K0.00%Q2 2026
08
WOLVERINE ASSET MANAGEMENT LLC
CIK 0001279891
$221K17K0.00%Q3 2026
09
Vestcor Inc
CIK 0001536925
$103K7K0.00%Q3 2026
10
CIBC Private Wealth Group LLC
CIK 0001298088
$25K1K0.00%Q4 2025
11
UBS Group AG
CIK 0001610520
$6K4430.00%Q3 2026
12
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025